| J9271 | Injection, pembrolizumab, 1 mg | 15,000 | $40 | $645K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 11,880 | $40 | $451.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $100 | $53.1K |
| J0897 | Injection, denosumab, 1 mg | 2,160 | $20 | $41K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,000 | $20 | $34K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $110 | $33K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 170 | $150 | $24.9K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,460 | $1 | $20.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 250 | $70 | $16K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 150 | $60 | $8.8K |